Scholarly Index
Pascal Bonnabry
University of Geneva; 4,294 total citations; 279 total publications; best world rank #3
University of Geneva
4,294Total citations
279Total publications
35H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Safe Handling of Antineoplastic Drugs | Lifetime | 7 | CH 1 | 98.20 |
| Pharmaceutical studies and practices | Lifetime | 392 | CH 4 | 97.10 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 424 | CH 5 | 96.82 |
| Patient Safety and Medication Errors | Lifetime | 218 | CH 5 | 97.00 |
| Electronic Health Records Systems | Lifetime | 628 | CH 7 | 92.31 |
| Pharmacy and Medical Practices | Lifetime | 488 | CH 3 | 85.84 |
| Intravenous Infusion Technology and Safety | Lifetime | 90 | CH 2 | 81.52 |
| Chemotherapy-related skin toxicity | Lifetime | 857 | CH 18 | 80.73 |
| Medical Device Sterilization and Disinfection | Lifetime | 425 | CH 9 | 81.54 |
| Healthcare Technology and Patient Monitoring | Lifetime | 878 | CH 9 | 80.42 |
| Safe Handling of Antineoplastic Drugs | 2021-2025 | 3 | CH 1 | 92.42 |
| Pharmaceutical Practices and Patient Outcomes | 2021-2025 | 520 | CH 11 | 89.00 |
| Pharmaceutical studies and practices | 2021-2025 | 432 | CH 11 | 83.80 |
| Patient Safety and Medication Errors | 2021-2025 | 253 | CH 7 | 83.79 |
| Simulation-Based Education in Healthcare | 2021-2025 | 669 | CH 17 | 74.61 |
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 844 | CH 8 | 51.87 |